The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2025
Journal Information
Full text access
¿Ofrece ventajas la inducción inmunosupresora con globulina antitimocítica frente a los anticuerpos monoclonales anti IL-2R en pacientes con trasplante renal de cadáver que tienen un alto riesgo de función retrasada del injerto o rechazo agudo?
Does immunosuppressive induction with anti-thymocyte globulin offer any advantage over anti-IL-2R monoclonal antibodies in patients with deaddonor renal transplant and high risk for delayed graft function or acute rejection?
Visits
7974
J. J. Amenábar Iríbar, F. J. García López
This item has received
Article information
Full text is only available in PDF




